Julie Cherrington

Dr Julie Cherrington is an experienced life science executive with a strong track record in bringing drugs into the clinic and through to commercialisation, and particular expertise in the oncology setting. She is also an accomplished company builder and has previously served as President and Chief Executive Officer at several biotechnology companies in the US West Coast, Canada and Australia. Julie holds a BS in biology and an MS in microbiology from the University of California, Davis. She earned a PhD in microbiology and immunology from the University of Minnesota and Stanford University. She completed a postdoctoral fellowship at the University of California, San Francisco. Previously, Julie was a non-executive director of Mirati Therapeutics.

Importance of contribution

Julie brings extensive understanding of the US regulatory and clinical development environment. Her experience of bringing drugs through the clinic and to commercialisation in the US will help the Syncona Board to understand the strategic needs of the business in North America and beyond.

Date of appointment

1 February 2022

Committee memberships

• Audit Committee

Current positions

• Non-Executive Director of Elevation Oncology, Inc. (NASDAQ: ELEV)
• Chair of Actym Therapeutics and Tolremo Therapeutics
• Venture Partner at Brandon Capital
• Non-Executive Director of a number of other early-stage private life science companies, including Sardona Therapeutics